stars 1 stars 2 stars 3

Cell2B is a biotechnology company dedicated to the development of a new line of healthcare therapies to prevent and treat organ rejection in patients undergoing organ or tissue transplants. Cell-based therapy has the potential to impact the life of more than 175,000 patients per year in Europe. Cell2B focuses on the development and processing of cell-based therapies for treating patients and improving their quality of life. Cell2B, incorporated in 2011, also focuses on research and development (R&D) of new cellular therapies for clinical use and offers complementary activities to R&D in the cell therapy space. R&D in cellular therapy is crucial in Cell2B’s vision, it enables to improve therapeutic solutions for the patients.

View Top Employees from Cell2B

Cell2B Questions

The Cell2B annual revenue was $5 million in 2024.

Cell2B is based in Cantanhede, Coimbra.

The NAICS codes for Cell2B are [54, 54171, 541711, 541, 5417].

The SIC codes for Cell2B are [80, 283, 28].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users